בי.אם.די. גרנולות % 10 וטרינרי Израел - иврит - Ministry of Health

בי.אם.די. גרנולות % 10 וטרינרי

zoetis israel holding b.v., israel - bacitracin methylene disalicylate - פרמיקס - bacitracin methylene disalicylate 10 %w/w

קימריה Израел - иврит - Ministry of Health

קימריה

novartis israel ltd - tisagenlecleucel - tisagenlecleucel

בודסון 3 מג כמוסות Израел - иврит - Ministry of Health

בודסון 3 מג כמוסות

rafa laboratories ltd - budesonide - קפסולות - budesonide 3 mg - budesonide - budesonide - for the induction and maintenance of remission in patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.

אסאקול 400 Израел - иврит - Ministry of Health

אסאקול 400

tradis gat ltd - mesalazine - טבליות עם ציפוי אנטרי - mesalazine 400 mg - mesalazine - mesalazine - maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease.

אסאקול 800 Израел - иврит - Ministry of Health

אסאקול 800

tradis gat ltd - mesalazine - טבליות עם ציפוי אנטרי - mesalazine 800 mg - mesalazine - mesalazine - maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease.

קואט DVI 250 Израел - иврит - Ministry of Health

קואט dvi 250

padagis israel agencies ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 250 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

קואט DVI 500 Израел - иврит - Ministry of Health

קואט dvi 500

padagis israel agencies ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 500 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

קואט DVI 1000 Израел - иврит - Ministry of Health

קואט dvi 1000

padagis israel agencies ltd, israel - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 1000 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

ונופר Израел - иврит - Ministry of Health

ונופר

cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.

ונופר Израел - иврит - Ministry of Health

ונופר

cts ltd - ferrous as iron iii hydroxide sucrose complex - תמיסה להזרקה - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin.